Hypertriglyceridemia

S7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results

Hot off the European Society of Cardiology Congress in Munich, this Lipid Insights episode takes a closer look at a…

The Lipid Panel – Hypertriglyceridemia

The Lipid Panel – Hypertriglyceridemia in Patients with T2DM

Icosapent Ethyl-Treated Hypertriglyceridemia to Reduce ASCVD Residual Risk

The Reduction of Cardiovascular Events with Icosapent Ethyl Intervention Trial (REDUCE-IT) as authored by Bhatt, DL et al, shows strong…

Practical Pearls – TG-Targets ApoC3 & ANGPTL3

National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk

The 2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol reaffirmed that lifestyle changes and…

Hypertriglyceridemia and the Risk of Cardiovascular Disease and Pancreatitis in a Veteran Population

The Veterans Health Administration (VA) is the nation’s largest integrated health care delivery system serving more than 11 million patients.…

Practical Approaches to Dietary Management of Hypertriglyceridemia

Nutrition Recommendations for HypertriglyceridemiaHigh triglycerides (TG) are a target for atherosclerotic cardiovascular disease (ASCVD) risk reduction.1-5 Despite the use of…

Therapies for Treating Hypertriglyceridemia

Many observational studies have established a link between elevated triglycerides and adverse cardiovascular events.1 Experimental and Mendelian randomization studies have…

Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association

Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder characterized by extreme hypertriglyceridemia and a high risk of recurrent…

Management of Hypertriglyceridemia in a Patient Considered an Undocumented Immigrant

IntroductionThe management of elevated triglycerides is a means by which the burden of Atherosclerotic Cardiovascular Disease(ASCVD) may be reduced and…

Renewed Justification for Triglyceride-Lowering Therapy: Insight from REDUCE-IT and Previous Fibrate Trials

An accumulating body of evidence has implicated hypertriglyceridemia as a treatable risk factor for the prevention of atherosclerotic cardiovascular diseases…

Severe Hypertriglyceridemia in a 40-Year-Old Woman: Using the ApoB App to Confirm a Diagnosis and Target Future Cardiovascular Risk

Case History Mary is a 40-year-old school teacher who was referred for severe elevation of triglycerides (TGs). She has a…